Back to companies

RegenxBio Inc: Patents

Want to continue viewing company data?

Sign up for exclusive competitve intelligence.

Create account

View up-to-date information on RegenxBio Inc patents, including inventor and filing insights.

Patent Trends

Publication Identifier Document Type Title Classification-CPC Publication Date
EP3687464A4 Search Report BEHANDLUNG VON AUGENERKRANKUNGEN MIT VOLLSTÄNDIG HUMANEM, POSTTRANSLATIONAL MODIFIZIERTEM ANTI-VEGF-FAB C07K16/22; A61K9/0048; A61K2039/53; A61M25/0194; A61F9/0017; C07K2317/40; C07K2317/41; C12N7/00; A61M5/32; A61K2039/505; C07K2317/21; A61M25/0084; C12N2750/14171; A61K48/00; A61K9/0019; C12N15/86; A61M2210/0612; C07K2317/24; C07K2317/622; A61P27/02; A61M2025/0089; C07K2317/54; A61K2039/54; C07K2317/565; C07K2317/55; C12N2750/14143 29 Sep 2021
US20210292789A1 Application TREATMENT OF MUCOPOLYSACCHARIDOSIS IVA A61K48/0058; C12N2830/008; C12N15/86; C12Y301/06004; C12N2750/14143 23 Sep 2021
US20210292789A1 Application TREATMENT OF MUCOPOLYSACCHARIDOSIS IVA A61Q19/00; A61K38/00; C12Y301/06004; A61P19/00; C12N2830/008; C07K2319/00; C12N15/86; A01K2267/0306; A61K48/0058; A01K2227/105; C12N2750/14143; A01K2217/054; C12N9/16 23 Sep 2021
EP3880235A1 Application GENTHERAPIE VON NEURONALEN ZEROID-LIPOFUSCINOSEN C12N9/48; C12N15/85; C12N15/86; A61K38/48; C07K14/81; A61K48/00 22 Sep 2021
WO2020219868A9 Search Report FULLY-HUMAN POST-TRANSLATIONALLY MODIFIED ANTIBODY THERAPEUTICS A61P17/00; C07K2317/21; C12N2750/14141; A61K2039/505; C12N15/86; C07K16/40; A61K2039/5256 16 Sep 2021
Discover Company Analytics for more exclusive patent trend analysis Discover Company Analytics for more exclusive patent trend analysis Get Started

Top Inventors by Filings (Count by publication)

Name Count
Identify the top inventors associated with your target company when you subscribe Identify the top inventors associated with your target company when you subscribe Learn More